162 related articles for article (PubMed ID: 8813337)
1. Molecular genetics of antithrombin deficiency.
Lane DA; Kunz G; Olds RJ; Thein SL
Blood Rev; 1996 Jun; 10(2):59-74. PubMed ID: 8813337
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin: structure, genomic organization, function and inherited deficiency.
Lane DA; Caso R
Baillieres Clin Haematol; 1989 Oct; 2(4):961-98. PubMed ID: 2688761
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III: summary of first database update.
Lane DA; Olds RJ; Thein SL
Nucleic Acids Res; 1994 Sep; 22(17):3556-9. PubMed ID: 7937056
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin: molecular basis of deficiency.
Bayston TA; Lane DA
Thromb Haemost; 1997 Jul; 78(1):339-43. PubMed ID: 9198176
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.
Martínez-Martínez I; Ordóñez A; Navarro-Fernández J; Pérez-Lara A; Gutiérrez-Gallego R; Giraldo R; Martínez C; Llop E; Vicente V; Corral J
Haematologica; 2010 Aug; 95(8):1358-65. PubMed ID: 20435622
[TBL] [Abstract][Full Text] [Related]
7. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin and its deficiency states.
Lane DA; Olds RR; Thein SL
Blood Coagul Fibrinolysis; 1992 Jun; 3(3):315-41. PubMed ID: 1643210
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin and its inherited deficiency states.
van Boven HH; Lane DA
Semin Hematol; 1997 Jul; 34(3):188-204. PubMed ID: 9241705
[TBL] [Abstract][Full Text] [Related]
10. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.
Picard V; Nowak-Göttl U; Biron-Andreani C; Fouassier M; Frere C; Goualt-Heilman M; de Maistre E; Regina S; Rugeri L; Ternisien C; Trichet C; Vergnes C; Aiach M; Alhenc-Gelas M
Hum Mutat; 2006 Jun; 27(6):600. PubMed ID: 16705712
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of antithrombin deficiency.
Luxembourg B; Delev D; Geisen C; Spannagl M; Krause M; Miesbach W; Heller C; Bergmann F; Schmeink U; Grossmann R; Lindhoff-Last E; Seifried E; Oldenburg J; Pavlova A
Thromb Haemost; 2011 Apr; 105(4):635-46. PubMed ID: 21264449
[TBL] [Abstract][Full Text] [Related]
12. Antithrombin: in control of coagulation.
Quinsey NS; Greedy AL; Bottomley SP; Whisstock JC; Pike RN
Int J Biochem Cell Biol; 2004 Mar; 36(3):386-9. PubMed ID: 14687916
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
14. SERPINC1 gene mutations in antithrombin deficiency.
Mulder R; Croles FN; Mulder AB; Huntington JA; Meijer K; Lukens MV
Br J Haematol; 2017 Jul; 178(2):279-285. PubMed ID: 28317092
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin p.Thr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency.
Orlando C; de la Morena-Barrio B; Pareyn I; Vanhoorelbeke K; Martínez-Martínez I; Vicente V; Corral J; Jochmans K; de la Morena-Barrio ME
Thromb Haemost; 2021 Feb; 121(2):182-191. PubMed ID: 32920809
[TBL] [Abstract][Full Text] [Related]
16. High levels of latent antithrombin in plasma from patients with antithrombin deficiency.
de la Morena-Barrio M; Sandoval E; Llamas P; Wypasek E; Toderici M; Navarro-Fernández J; Rodríguez-Alen A; Revilla N; López-Gálvez R; Miñano A; Padilla J; de la Morena-Barrio B; Cuesta J; Corral J; Vicente V
Thromb Haemost; 2017 May; 117(5):880-888. PubMed ID: 28229161
[TBL] [Abstract][Full Text] [Related]
17. An overview of the mechanism of action of antithrombin and its inherited deficiency states.
Blajchman MA
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S5-11; discussion S59-64. PubMed ID: 8186357
[TBL] [Abstract][Full Text] [Related]
18. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
[TBL] [Abstract][Full Text] [Related]
19. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.
Watton J; Longstaff C; Lane DA; Barrowcliffe TW
Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518
[TBL] [Abstract][Full Text] [Related]
20. The genetics of antithrombin.
Corral J; de la Morena-Barrio ME; Vicente V
Thromb Res; 2018 Sep; 169():23-29. PubMed ID: 30005274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
